NCT07010328

Brief Summary

Postural abnormalities are highly disabling complications of Parkinson's disease (PD). These include camptocormia, anterocollis, and Pisa Syndrome (PS). PS is characterized by a lateral trunk flexion (LTF) typically exceeding 10 degrees, often accompanied by axial rotation, asymmetric shoulder positioning, and poor awareness of the postural alteration. This condition worsens during upright activities and improves in a supine position. Patients with PD and PS are characterized by more pronounced motor asymmetry, a disorganized trunk muscle activity, back pain, balance issues, and reduced quality of life compared to PD patients without postural disorders. Camptocormia, another disabling postural anomaly, involves an anterior trunk flexion that also improves when lying down. Both PS and camptocormia are challenging to treat, with limited and short-lasting benefits from current multidisciplinary approaches, including medication, physiotherapy, botulinum toxin injections, and transcranial direct current stimulation (tDCS). Given the limitations of traditional rehabilitation strategies, there is a growing need for innovative and personalized approaches. In this context, advanced technologies such as artificial intelligence (AI) offer new possibilities for home-based treatment. This study aims to evaluate the feasibility of using a real-time visual feedback system powered by AI as a complementary intervention following inpatient neurorehabilitation for PD patients with trunk postural disorders (PS or camptocormia). A secondary objective is to assess whether an AI-guided, personalized exercise program can help maintain improvements in posture, mobility, and quality of life in the medium term. By integrating quantitative and qualitative outcomes, this study seeks to fill a gap in the literature and explore the potential of AI-driven home rehabilitation to support long-term functional gains and foster greater independence and well-being in people with PD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
32mo left

Started Oct 2024

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Oct 2024Dec 2028

Study Start

First participant enrolled

October 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

June 8, 2025

Status Verified

May 1, 2025

Enrollment Period

3.3 years

First QC Date

May 20, 2025

Last Update Submit

May 29, 2025

Conditions

Keywords

Physical activityNeurological disorderArtificial Intelligence

Outcome Measures

Primary Outcomes (1)

  • System Usability Scale (SUS)

    System Usability Scale (SUS) (continuous variable, score ranging from 0 to 100, with higher scores indicating better perceived usability of the system)

    Single evaluation after 6-8 weeks from intervention (T1)

Secondary Outcomes (8)

  • Static trunk cinematic analysis of movement

    Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)

  • Dynamic trunk cinematic analysis of movement

    Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)

  • Time Up and Go test

    Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)

  • Inertial Gait Analysis

    Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)

  • 30 second chair stand test

    Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)

  • +3 more secondary outcomes

Study Arms (1)

PD-Subjects

EXPERIMENTAL

Subjects with Parkinson's Disease and postural disorders (Pisa syndrome or camptocormia).

Procedure: NeurorehabilitationDevice: AI-based home rehabilitation for postural disorders

Interventions

4-8 weeks of inhospital Neurorehabilitation

PD-Subjects

AI-based home rehabilitation for postural disorders by means of the Kemtai platform.

PD-Subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 18 years
  • Diagnosis of Parkinson's disease according to MDS criteria
  • Hoehn and Yahr stage ≤ III
  • Clinical diagnosis of camptocormia (presence of an anterior axial trunk flexion of at least 30°), or of Pisa Syndrome (presence of a lateral trunk flexion of at least 10°) at the time of enrollment (T0)
  • Mini-Mental State Examination (MMSE) score \> 23

You may not qualify if:

  • Atypical parkinsonian syndromes
  • History of spinal surgery
  • Previous vertebral trauma
  • Current or past spinal tumors or infections
  • Idiopathic scoliosis
  • Ankylosing spondylitis
  • Spinal canal stenosis
  • Other neurological conditions
  • Severe dyskinesias

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Mondino Foundation

Pavullo nel Frignano, Pavia, 27100, Italy

RECRUITING

Related Publications (3)

  • Hoshiyama M, Kaneoke Y, Koike Y, Takahashi A, Watanabe S. Hypokinesia of associated movement in Parkinson's disease: a symptom in early stages of the disease. J Neurol. 1994 Aug;241(9):517-21. doi: 10.1007/BF00873512.

    PMID: 7798998BACKGROUND
  • Fasano A, Geroin C, Berardelli A, Bloem BR, Espay AJ, Hallett M, Lang AE, Tinazzi M. Diagnostic criteria for camptocormia in Parkinson's disease: A consensus-based proposal. Parkinsonism Relat Disord. 2018 Aug;53:53-57. doi: 10.1016/j.parkreldis.2018.04.033. Epub 2018 May 8.

    PMID: 29759930BACKGROUND
  • Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, Bloem BR. Postural deformities in Parkinson's disease. Lancet Neurol. 2011 Jun;10(6):538-49. doi: 10.1016/S1474-4422(11)70067-9. Epub 2011 Apr 22.

    PMID: 21514890BACKGROUND

MeSH Terms

Conditions

Parkinson DiseaseSedentary BehaviorMotor ActivityNervous System Diseases

Interventions

Neurological Rehabilitation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Luca Martinis

    IRCCS Mondino Foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2025

First Posted

June 8, 2025

Study Start

October 1, 2024

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

June 8, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The final anonymized database will be uploaded in the Zenodo platform.

Locations